Stephen K. Brannan, Chief Medical Officer at Karuna Therapeutics, Inc. (KRTX), sold 10,000 shares at $200.76 ($2.0M) on 2022-12-09, disclosed to the SEC on 2022-12-12.
Open-market sale of $2.0M KRTX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $200.76 | 1,363 | $274K | 13.6% |
| 2 | $200.76 | 1,363 | $274K | 13.6% |
| 3 | $200.76 | 3,637 | $730K | 36.4% |
| 4 | $200.76 | 3,637 | $730K | 36.4% |
| Total | $200.76 avg | 10,000 | $2.0M | 100% |
| Filing → |
| KRTX | SELL | 2024-02-12 | $3.2M | — | Filing → |
| KRTX | SELL | 2024-01-09 | $4.8M | — | Filing → |
| KRTX | SELL | 2023-12-12 | $4.0M | — | Filing → |